Lau Bi-Wen, Lim Dee-Zhen, Capon Francesca, Barker Jonathan N, Choon Siew-Eng
School of Medicine and Health Sciences, Monash University, Melbourne, Vic., Australia.
Division of Genetics and Molecular Medicine, King's College, London, UK.
Int J Dermatol. 2017 Apr;56(4):392-399. doi: 10.1111/ijd.13489. Epub 2017 Feb 14.
Limited information exists regarding juvenile generalized pustular psoriasis (GPP). We aim to determine the clinical profile and outcome of Malaysians with juvenile GPP.
Review of hospital case notes on patients with juvenile GPP.
Twenty-seven patients with juvenile GPP were identified. Female to male ratio was 1.4:1. The median age at onset of GPP was 6.5 years. Ten patients had prior psoriasis with a median pre-pustular duration of 2.7 years. Onset of GPP was earlier in patients without prior psoriasis (5.1 years vs. 12.0 years, P = 0.002). Precipitating factors identified included stress, upper respiratory tract infection, systemic steroid use, vaccination, and pregnancy. A positive family history of psoriasis and GPP was present in six and one patient(s), respectively. Twenty-one patients had acute, five annular, and one localized variant of GPP. Arthritis was present in 22.2%. Fever, leukocytosis, and transaminitis were mainly seen in patients with acute GPP at 80.9, 72.2, and 11.1%, respectively. Among 20 patients screened, eight carry IL36RN variants and one has CARD14 mutation. IL36RN-positive patients have more severe disease characterized by early onset, low prevalence of prior plaque psoriasis, high prevalence of systemic inflammation, and need for continuous long-term systemic therapy. Acitretin and cyclosporine were effective in aborting acute GPP in 100% of 16 and 66.7% of six patients treated, respectively. However, relapses were common. Only three of the 17 patients whose initial acute GPP was controlled with systemic agents were successfully weaned off treatment.
Juvenile GPP is a chronic recalcitrant disease. IL36RN-positive patients have more severe disease.
关于青少年泛发性脓疱型银屑病(GPP)的信息有限。我们旨在确定马来西亚青少年GPP患者的临床特征和预后。
回顾青少年GPP患者的医院病历。
共确定了27例青少年GPP患者。女性与男性比例为1.4:1。GPP发病的中位年龄为6.5岁。10例患者既往有银屑病,脓疱出现前的中位病程为2.7年。无既往银屑病的患者GPP发病更早(5.1岁对12.0岁,P = 0.002)。确定的诱发因素包括压力、上呼吸道感染、全身使用类固醇、接种疫苗和妊娠。分别有6例和1例患者有银屑病和GPP的阳性家族史。21例患者为急性GPP,5例为环状GPP,1例为局限性GPP。22.2%的患者有关节炎。发热、白细胞增多和转氨酶升高主要见于急性GPP患者,分别为80.9%、72.2%和11.1%。在20例接受筛查的患者中,8例携带IL36RN变异,1例有CARD14突变。IL36RN阳性患者病情更严重,其特征为发病早、既往斑块状银屑病患病率低、全身炎症患病率高以及需要持续长期的全身治疗。阿维A和环孢素分别使16例接受治疗患者中的100%和6例患者中的66.7%的急性GPP得到缓解。然而,复发很常见。17例初始急性GPP通过全身药物得到控制的患者中,只有3例成功停药。
青少年GPP是一种慢性难治性疾病。IL36RN阳性患者病情更严重。